Although T-cell acute lymphoblastic leukemia (T-ALL) is similar in many ways to CLL and AML, it has not responded well to venetoclax or navitoclax BH3 mimetics, presumably because it expresses active pro-survival proteins other than BCL-2, BCL-XL, and BCL-W. This evidence concerns the gene BCL2 and acute myeloid leukemia.